A phase IV monocentre study to evaluate palonosetron in nausea/vomiting prevention in patients with breast or colon cancer, treated with moderately emotogenic chemotherapic agents.
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2011
At a glance
- Drugs Palonosetron (Primary) ; Dexamethasone
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 21 Jun 2011 New trial record